クラッベ病薬の世界市場：市場規模・現状・予測

• 英文タイトル：Global Krabbe Disease Drugs Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST05302 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、クラッベ病薬の世界市場について調査・分析し、クラッベ病薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗けいれん薬、筋弛緩薬、その他）、用途別（病院、診療所、研究センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のクラッベ病薬市場動向 ・主要企業別マーケットシェア ・クラッベ病薬の種類別市場規模2014-2019 （抗けいれん薬、筋弛緩薬、その他） ・クラッベ病薬の用途別市場規模2014-2019 （病院、診療所、研究センター、その他） ・クラッベ病薬の北米市場：主要企業・種類別/用途別市場規模 ・クラッベ病薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・クラッベ病薬の中国市場：主要企業・種類別/用途別市場規模 ・クラッベ病薬の日本国内市場：主要企業・種類別/用途別市場規模 ・クラッベ病薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・クラッベ病薬のインド市場：主要企業・種類別/用途別市場規模 ・クラッベ病薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （GlaxoSmithKline、Johnson & Johnson、Novartis、Pfizer、Sanofi、Abbott Laboratories、Teva Pharmaceutical、Shire、UCB Pharmaceuticals） ・クラッベ病薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to make myelin in a human body.Globally North America is the largest market for Krabbe disease treatment. Europe is the second-largest market and Asia Pacific is expected to grow at a fastest rate.
In 2018, the global Krabbe Disease Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Krabbe Disease Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Krabbe Disease Drugs development in United States, Europe and China.

The key players covered in this study
GlaxoSmithKline
Johnson & Johnson
Novartis
Pfizer
Sanofi
Abbott Laboratories
Teva Pharmaceutical
Shire
UCB Pharmaceuticals

Market segment by Type, the product can be split into
Anticonvulsants
Muscle Relaxants
Others

Market segment by Application, split into
Hospitals
Clinics
Research Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Krabbe Disease Drugs status, future forecast, growth opportunity, key market and key players.
To present the Krabbe Disease Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Krabbe Disease Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Krabbe Disease Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Anticonvulsants
1.4.3 Muscle Relaxants
1.4.4 Others
1.5 Market by Application
1.5.1 Global Krabbe Disease Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Krabbe Disease Drugs Market Size
2.2 Krabbe Disease Drugs Growth Trends by Regions
2.2.1 Krabbe Disease Drugs Market Size by Regions (2014-2025)
2.2.2 Krabbe Disease Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Krabbe Disease Drugs Market Size by Manufacturers
3.1.1 Global Krabbe Disease Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Krabbe Disease Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Krabbe Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Krabbe Disease Drugs Key Players Head office and Area Served
3.3 Key Players Krabbe Disease Drugs Product/Solution/Service
3.4 Date of Enter into Krabbe Disease Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Krabbe Disease Drugs Market Size by Type (2014-2019)
4.2 Global Krabbe Disease Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Krabbe Disease Drugs Market Size (2014-2019)
5.2 Krabbe Disease Drugs Key Players in United States
5.3 United States Krabbe Disease Drugs Market Size by Type
5.4 United States Krabbe Disease Drugs Market Size by Application

6 Europe
6.1 Europe Krabbe Disease Drugs Market Size (2014-2019)
6.2 Krabbe Disease Drugs Key Players in Europe
6.3 Europe Krabbe Disease Drugs Market Size by Type
6.4 Europe Krabbe Disease Drugs Market Size by Application

7 China
7.1 China Krabbe Disease Drugs Market Size (2014-2019)
7.2 Krabbe Disease Drugs Key Players in China
7.3 China Krabbe Disease Drugs Market Size by Type
7.4 China Krabbe Disease Drugs Market Size by Application

8 Japan
8.1 Japan Krabbe Disease Drugs Market Size (2014-2019)
8.2 Krabbe Disease Drugs Key Players in Japan
8.3 Japan Krabbe Disease Drugs Market Size by Type
8.4 Japan Krabbe Disease Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Krabbe Disease Drugs Market Size (2014-2019)
9.2 Krabbe Disease Drugs Key Players in Southeast Asia
9.3 Southeast Asia Krabbe Disease Drugs Market Size by Type
9.4 Southeast Asia Krabbe Disease Drugs Market Size by Application

10 India
10.1 India Krabbe Disease Drugs Market Size (2014-2019)
10.2 Krabbe Disease Drugs Key Players in India
10.3 India Krabbe Disease Drugs Market Size by Type
10.4 India Krabbe Disease Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Krabbe Disease Drugs Market Size (2014-2019)
11.2 Krabbe Disease Drugs Key Players in Central & South America
11.3 Central & South America Krabbe Disease Drugs Market Size by Type
11.4 Central & South America Krabbe Disease Drugs Market Size by Application

12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Krabbe Disease Drugs Introduction
12.1.4 GlaxoSmithKline Revenue in Krabbe Disease Drugs Business (2014-2019)
12.1.5 GlaxoSmithKline Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Krabbe Disease Drugs Introduction
12.2.4 Johnson & Johnson Revenue in Krabbe Disease Drugs Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Krabbe Disease Drugs Introduction
12.3.4 Novartis Revenue in Krabbe Disease Drugs Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Krabbe Disease Drugs Introduction
12.4.4 Pfizer Revenue in Krabbe Disease Drugs Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Krabbe Disease Drugs Introduction
12.5.4 Sanofi Revenue in Krabbe Disease Drugs Business (2014-2019)
12.5.5 Sanofi Recent Development
12.6 Abbott Laboratories
12.6.1 Abbott Laboratories Company Details
12.6.2 Company Description and Business Overview
12.6.3 Krabbe Disease Drugs Introduction
12.6.4 Abbott Laboratories Revenue in Krabbe Disease Drugs Business (2014-2019)
12.6.5 Abbott Laboratories Recent Development
12.7 Teva Pharmaceutical
12.7.1 Teva Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Krabbe Disease Drugs Introduction
12.7.4 Teva Pharmaceutical Revenue in Krabbe Disease Drugs Business (2014-2019)
12.7.5 Teva Pharmaceutical Recent Development
12.8 Shire
12.8.1 Shire Company Details
12.8.2 Company Description and Business Overview
12.8.3 Krabbe Disease Drugs Introduction
12.8.4 Shire Revenue in Krabbe Disease Drugs Business (2014-2019)
12.8.5 Shire Recent Development
12.9 UCB Pharmaceuticals
12.9.1 UCB Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Krabbe Disease Drugs Introduction
12.9.4 UCB Pharmaceuticals Revenue in Krabbe Disease Drugs Business (2014-2019)
12.9.5 UCB Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Krabbe Disease Drugs Key Market Segments
Table Key Players Krabbe Disease Drugs Covered
Table Global Krabbe Disease Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Krabbe Disease Drugs Market Size Market Share by Type 2014-2025
Figure Anticonvulsants Figures
Table Key Players of Anticonvulsants
Figure Muscle Relaxants Figures
Table Key Players of Muscle Relaxants
Figure Others Figures
Table Key Players of Others
Table Global Krabbe Disease Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Research Centers Case Studies
Figure Others Case Studies
Figure Krabbe Disease Drugs Report Years Considered
Table Global Krabbe Disease Drugs Market Size 2014-2025 (Million US$)
Figure Global Krabbe Disease Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Krabbe Disease Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Krabbe Disease Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Krabbe Disease Drugs Market Share by Regions 2014-2019
Figure Global Krabbe Disease Drugs Market Share by Regions 2014-2019
Figure Global Krabbe Disease Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Krabbe Disease Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Krabbe Disease Drugs Market Share by Manufacturers (2014-2019)
Figure Global Krabbe Disease Drugs Market Share by Manufacturers in 2018
Table Global Krabbe Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Krabbe Disease Drugs Product/Solution/Service
Table Date of Enter into Krabbe Disease Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Krabbe Disease Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Krabbe Disease Drugs Market Size Share by Type (2014-2019)
Figure Global Krabbe Disease Drugs Market Size Market Share by Type (2014-2019)
Table Global Krabbe Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Krabbe Disease Drugs Market Size Share by Application (2014-2019)
Figure Global Krabbe Disease Drugs Market Size Market Share by Application (2014-2019)
Figure Global Krabbe Disease Drugs Revenue Market Share by Application in 2018
Figure United States Krabbe Disease Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Krabbe Disease Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Krabbe Disease Drugs Market Share (2018-2019)
Table United States Krabbe Disease Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Krabbe Disease Drugs Market Share by Type (2014-2019)
Table United States Krabbe Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Krabbe Disease Drugs Market Share by Application (2014-2019)
Figure Europe Krabbe Disease Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Krabbe Disease Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Krabbe Disease Drugs Market Share (2018-2019)
Table Europe Krabbe Disease Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Krabbe Disease Drugs Market Share by Type (2014-2019)
Table Europe Krabbe Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Krabbe Disease Drugs Market Share by Application (2014-2019)
Figure China Krabbe Disease Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Krabbe Disease Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Krabbe Disease Drugs Market Share (2018-2019)
Table China Krabbe Disease Drugs Market Size by Type (2014-20189) (Million US$)
Table China Krabbe Disease Drugs Market Share by Type (2014-2019)
Table China Krabbe Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table China Krabbe Disease Drugs Market Share by Application (2014-2019)
Figure Japan Krabbe Disease Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Krabbe Disease Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Krabbe Disease Drugs Market Share (2018-2019)
Table Japan Krabbe Disease Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Krabbe Disease Drugs Market Share by Type (2014-2019)
Table Japan Krabbe Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Krabbe Disease Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Krabbe Disease Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Krabbe Disease Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Krabbe Disease Drugs Market Share (2018-2019)
Table Southeast Asia Krabbe Disease Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Krabbe Disease Drugs Market Share by Type (2014-2019)
Table Southeast Asia Krabbe Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Krabbe Disease Drugs Market Share by Application (2014-2019)
Figure India Krabbe Disease Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Krabbe Disease Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Krabbe Disease Drugs Market Share (2018-2019)
Table India Krabbe Disease Drugs Market Size by Type (2014-2019) (Million US$)
Table India Krabbe Disease Drugs Market Share by Type (2014-2019)
Table India Krabbe Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table India Krabbe Disease Drugs Market Share by Application (2014-2019)
Figure Central & South America Krabbe Disease Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Krabbe Disease Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Krabbe Disease Drugs Market Share (2018-2019)
Table Central & South America Krabbe Disease Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Krabbe Disease Drugs Market Share by Type (2014-2019)
Table Central & South America Krabbe Disease Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Krabbe Disease Drugs Market Share by Application (2014-2019)
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Krabbe Disease Drugs Business (2014-2019) (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Krabbe Disease Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Krabbe Disease Drugs Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Krabbe Disease Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Novartis Company Details
Table Novartis Revenue in Krabbe Disease Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Krabbe Disease Drugs Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Krabbe Disease Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Krabbe Disease Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Krabbe Disease Drugs Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Krabbe Disease Drugs Business (2014-2019)
Table Sanofi Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Krabbe Disease Drugs Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Krabbe Disease Drugs Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Krabbe Disease Drugs Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Krabbe Disease Drugs Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Shire Company Details
Table Shire Revenue in Krabbe Disease Drugs Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Krabbe Disease Drugs Business (2014-2019)
Table Shire Recent Development
Table UCB Pharmaceuticals Company Details
Table UCB Pharmaceuticals Revenue in Krabbe Disease Drugs Business (2014-2019)(Million US$)
Figure UCB Pharmaceuticals Revenue Growth Rate in Krabbe Disease Drugs Business (2014-2019)
Table UCB Pharmaceuticals Recent Development
Table Global Krabbe Disease Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Krabbe Disease Drugs Market Size Share by Regions (2019-2025)
Figure Global Krabbe Disease Drugs Market Size Share by Regions in 2025
Figure United States Krabbe Disease Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Krabbe Disease Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Krabbe Disease Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Krabbe Disease Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Krabbe Disease Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Krabbe Disease Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Krabbe Disease Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Krabbe Disease Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Krabbe Disease Drugs Market Size by Product (2019-2025)
Figure Global Krabbe Disease Drugs Market Size by Product in 2025
Table Global Krabbe Disease Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Krabbe Disease Drugs Market Size by Application (2019-2025)
Figure Global Krabbe Disease Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---